Articles | Open Access | https://doi.org/10.55640/

A NEW VIEW ON THE PATHOLOGY OF ANTIPHOSPHOLIPID SYNDROME COMBINED WITH PRE-ECLAMPSIA OF PREGNANCY

Salomova Shaxina Olimovna, Tuksanova Dilbar Ismatovna ,

Abstract

Antiphospholipid syndrome (APS) is a multisystem disease characterized by the production in the human body of large amounts of antibodies to phospholipids, the chemical structures that make up parts of the cell. APS is one of the most urgent multidisciplinary problems of modern medicine and is considered as a unique model of autoimmune thrombotic vasculopathy. APS is the cause of recurrent miscarriage in 27-42%. More often detected in women (5:1). In recent years, in the scientific field, we are increasingly faced with the problem of combining APS with other pathologies, for example, with hypertensive conditions during pregnancy. In this article, we have provided our opinion on APS associated hypertension during pregnancy.

Keywords

References

Bazovaya M.YU. Optimizaciya dispansernogo nablyudeniya v rannie sroki gestacii zhenshchin s otyagoshchennym akusherskim anamnezom: Avtoref. dis.kand. med. nauk. Moskva. - 2013. - 12s.

Kornyushina E.A. Sovremennye podhody k terapii antifosfolipidnogo sindroma pri beremennosti (klinicheskij sluchaj) // ZHurnal akusherstva i zhenskih boleznej. - 2018. - T. 67. - №6. - C. 100-105. doi: 10.17816/JOWD676100-105.

Kerchelaeva S.B. Znachenie antitel k fosfolipidam i fosfolipid svyazyvayushchim belkam pri nerazvivayushchejsya beremennosti// Ros.vestnik akushera-ginekologa. 2003. - tom 3, № 4. - S.11 - 16.

Negmatshaeva, H. N. Kliniko-laboratornoe obsledovanie vne beremennosti pacientok s antifosfolipidnym sindromom / H. N. // Medicina i zdravoohranenie : materialy V Mezhdunar. nauch. konf. (g. Kazan', maj 2017 g.). — Kazan' : Buk, 2017. — S. 63-65. —

Sidel'nikova V.M., Suhih G.T. Nevynashivanie beremennosti. - M.: MIA, 2010. [Sidel’nikova VM, Sukhikh GT. Nevynashivanie beremennosti. Moscow: MIA; 2010. (In Russ.)]

Tong M., Viall C. A., Chamley L. W. Antiphospholipid antibodies and the placenta: a systematic review of their in vitro effects and modulation by treatment (angl.) // Human Reproduction (angl.)russk. : journal. — 2014. — Vol. 21, no. 1. — P. 97—118. — doi:10.1093/humupd/dmu049. — PMID 25228006.

Ikhtiyarova, G.A., Dustova, N.K., Kudratova, R.R., Bakhramova, S.U., Khafizova, D.B. Pre-course training of women with reproductive loss of fetus in anamnesis (2021) Annals of the Romanian Society for Cell Biology, 25 (1), pp. 6219-6226.

Bakhramova, S.U., Ikhtiyarova, G.A., Dustova, N.K., Kudratova, R.R. Thrombophilic complications in the development of gestional hypertension (Review) (2021) Annals of the Romanian Society for Cell Biology, 25 (1), pp. 6198-6205.

de Jong P.G., Goddijn M., Middeldorp S. Antithrombotic therapy for pregnancy loss (angl.) // Human Reproduction (angl.)russk.. — 2013. — Vol. 19, no. 6. — P. 656—673. — doi:10.1093/humupd/dmt019. — PMID 23766357.

Ruffatti A, Favaro M, Brucato A, et al. Apheresis in high risk antiphospholipid syndrome pregnancy and autoimmune congenital heart block. Transfus Apher Sci. 2015;53(3):269-278. doi: 10.1016/j.transci.2015.11.006.

Article Statistics

Downloads

Download data is not yet available.

Copyright License

Download Citations

How to Cite

A NEW VIEW ON THE PATHOLOGY OF ANTIPHOSPHOLIPID SYNDROME COMBINED WITH PRE-ECLAMPSIA OF PREGNANCY. (2024). International Journal of Medical Sciences, 4(09), 96-100. https://doi.org/10.55640/